inflammatory bowel disease
Garvan Institute Gets A$11.6M From Australian Government to Develop Genomics-Based Disease Tests
Four teams will use genomics to improve the diagnosis and treatment of diseases including Parkinson's, inflammatory bowel disease, and rare genetic disorders.
Inflammatory Bowel Disease Genetics Understanding Expands With East Asian Analyses
A genome-wide association study and meta-analysis of tens of thousands of East Asian participants led to new genetic contributors to Crohn's disease and ulcerative colitis.
Data from several presentations at the American Society of Human Genetics annual meeting demonstrated the benefits of using diverse ancestries in human genetic studies.
Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth
Premium
The company realized it is costly to develop single-disease T-Detect assays and is deferring commercialization until a clear path to reimbursement is proven.
Boehringer Ingelheim, BiomX Embark on New Inflammatory Bowel Disease Biomarker Discovery Project
The deal is the second of its kind for the two companies following a 2020 partnership to investigate metagenomic markers of different IBD patient phenotypes.